Skip to main content
Log in

Uterine artery embolisation not a cost-effective alternative to myomectomy for uterine fibroids

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Rana D, et al. Uterine artery embolization or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial. BJOG: An International Journal of Obstetrics and Gynaecology : 30 May 2021. Available from: URL: http://doi.org/10.1111/1471-0528.16781

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uterine artery embolisation not a cost-effective alternative to myomectomy for uterine fibroids. PharmacoEcon Outcomes News 880, 33 (2021). https://doi.org/10.1007/s40274-021-7791-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7791-z

Navigation